PRURITUS
Clinical trials for PRURITUS explained in plain language.
Never miss a new study
Get alerted when new PRURITUS trials appear
Sign up with your email to follow new studies for PRURITUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a painless light zap your itch away?
Symptom relief Not yet recruitingThis early study is testing whether a non-invasive, low-level LED light device can safely reduce itching. Researchers will apply the light to the skin of 20 adults with mild to severe itch to see if it affects nerve signals and provides relief. The study uses a split-body design,…
Matched conditions: PRURITUS
Phase: EARLY_PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Apr 03, 2026 14:43 UTC
-
New drug trial targets debilitating itch in liver disease patients
Symptom relief Not yet recruitingThis study is testing whether an investigational drug called TH104 can safely reduce severe itching in people with primary biliary cholangitis (PBC), a chronic liver disease. Forty participants with moderate to severe itching will receive either TH104 or a placebo for six weeks, …
Matched conditions: PRURITUS
Phase: PHASE2 • Sponsor: Tharimmune Inc • Aim: Symptom relief
Last updated Apr 01, 2026 14:41 UTC
-
Battle against psoriasis itch: which drug works better?
Symptom relief Not yet recruitingThis study compares two existing medications—methotrexate and apremilast—to see which works better at reducing the severe itching that often accompanies psoriasis. Eighty adults with psoriasis and bothersome itching will take one of the two drugs for eight weeks. Researchers will…
Matched conditions: PRURITUS
Phase: PHASE4 • Sponsor: Zarmeen Khawar • Aim: Symptom relief
Last updated Mar 30, 2026 14:29 UTC